We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current QGEN market cap is 9.66B. The company's latest EPS is USD 2.1245 and P/E is 19.93.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 485.4M | 494.86M | 475.89M | 509.16M | 458.8M |
| Operating Income | 96.71M | 105.43M | 35.05M | 110.62M | 94.95M |
| Net Income | 85.04M | 80.79M | 77.82M | 97.66M | 80.67M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.53B | 1.87B | 2.25B | 2.14B | 1.97B |
| Operating Income | -47.45M | 383.92M | 635.68M | 533.32M | 417.23M |
| Net Income | -69.77M | 73.64M | 537.05M | 575.66M | 484.81M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 6.28B | 6.35B | 5.91B | 6.12B | 5.81B |
| Total Liabilities | 2.72B | 2.72B | 2.21B | 2.31B | 2.21B |
| Total Equity | 3.56B | 3.62B | 3.69B | 3.81B | 3.6B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 5.26B | 5.93B | 6.21B | 6.35B | 6.17B |
| Total Liabilities | 2.94B | 3.45B | 3.35B | 2.96B | 2.31B |
| Total Equity | 2.32B | 2.48B | 2.86B | 3.39B | 3.87B |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 71.93M | 183.4M | 308.09M | 459.46M | 133.08M |
| Investing | -433.85M | -277.57M | -29.2M | -87.66M | 6.43M |
| Financing | -9.83M | -25.3M | -426.39M | -433.83M | -292.09M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 367.03M | 492.27M | 675.99M | 751.12M | 492.78M |
| Investing | -236.96M | -503.06M | -211.7M | -735.58M | -94.53M |
| Financing | -661.75M | -74.32M | -177.8M | -152.65M | -460.61M |
| Market Cap | 9.66B |
| Price to Earnings Ratio | 19.93 |
| Price to Sales Ratio | 4.92 |
| Price to Cash Ratio | 14.48 |
| Price to Book Ratio | 2.5 |
| Dividend Yield | - |
| Shares Outstanding | 228.2M |
| Average Volume (1 week) | 903.48k |
| Average Volume (1 Month) | 946.8k |
| 52 Week Change | -10.35% |
| 52 Week High | 49.1739 |
| 52 Week Low | 35.8135 |
| Spread (Intraday) | 2.81 (6.32%) |
| Company Name | Qiagen NV |
| Address |
hulsterweg 82 venlo, limburg 5912-PL |
| Website | https://www.qiagen.com |
| Industry | biogenetic (human) (H4) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
